Proportion of fibrin and platelets differs in thrombi on ruptured and eroded coronary atherosclerotic plaques in humans

Heart

Volumn 91, Issue 4, 2005, Pages 526-530

  Sato, Y ^a   Hatakeyama, K ^a   Yamashita, A ^a   Marutsuka, K ^a   Sumiyoshi, A ^a   Asada, Yujiro ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRIN; THROMBOPLASTIN; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD CELL; CAUSE OF DEATH; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; JAPAN; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE; THROMBOGENESIS; THROMBUS; CORONARY ARTERY THROMBOSIS; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PLATELETS; C-REACTIVE PROTEIN; CORONARY ARTERIOSCLEROSIS; CORONARY THROMBOSIS; FEMALE; FIBRIN; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; THROMBOPLASTIN;

EID: 15844415674     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2004.034058     Document Type: Article

References (34)

1. Fuster V, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50.
2. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischaemic death, anacrescendo angina. Br Heart J 1985;53:363-73.
3. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93:1354-63.
4. Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336:1276-82.
5. Kojima S, Nonogi H, Miyao Y, et al. Is preinfarction angina related to the presence or absence of coronary plaque rupture? Heart 2000;83:64-8.
6. Arbustini E, Dal Bella B, Morbini P, et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 1999;82:269-72.
7. Fuster V. Acute coronary syndromes: the degree and morphology of coronary stenoses. J Am Coll Cardiol 2000;35:52B-4B.
8. Willerson JT, Golino P, Eidt J, et al. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation 1989;80:198-205.
9. Vorchheimer DA, Badimon JJ, Fuster V. Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease. JAMA 1999;281:1407-14.
10. Coller BS. Anti-GPIIb/IIIa drugs: current strategies and future directions. Thromb Haemost 2001;86:427-43.
11. Simoons ML. Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial. GUSTO IV-ACS Investigators. Lancet 2001;357:1915-24.
12. Davies MJ. Stability and instability: two faces of coronary atherosclerosis. Circulation 1996;94:2013-20.
13. Rentrop KP. Thrombi in acute coronary syndromes: revisited and revised. Circulation 2000;101:1619-26.
14. Wilcox JN, Smith KM, Schwartz SM, et al. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989;86:2839-43.
15. Taubman MB, Fallon JT, Schecter AD, et al. Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost 1997;78:200-4.
16. Hatakeyama K, Asada Y, Marutsuka K, et al. Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis 1997;133:213-9.
17. Hatakeyama K, Asada Y, Marutsuka K, et al. Expression of tissue factor in the rabbit aorta after balloon injury. Atherosclerosis 1998;139:265-71.
18. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
19. Kuller LH, Tracy RP. The role of inflammation in cardiovascular disease. Arterioscler Thromb Vasc Biol 2000;20:901.
20. Kurokawa T, Iwasa S, Kakinuma A, et al. Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator. Thromb Haemost 1991;66:684-93.
21. Gutstein DE, Fuster V. Pathophysiology and clinical significance of atherosclerotic plaque rupture. Cardiovasc Res 1999;41:323-33.
22. Hurlen M, Abdelnoor M, Smith P, et al. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 2002;347:969-974.
23. Van Es RF, Jonker JJ, Verheugt FW, et al. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet 2002;360:109-13.
24. Moons AH, Levi M, Peters RJ. Tissue factor and coronary artery disease. Cardiovasc Res 2002;53:313-25.
25. Misumi K, Ogawa H, Yasue H, et al. Comparison of plasma tissue factor levels in unstable and stable angina pectoris. Am J Cardiol 1998;81:22-6.
26. Giesen PL, Rauch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999;96:2311-5.
27. Torzewski M, Rist C, Mortensen RF, et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000;20:2094-9.
28. Yasojima K, Schwab C, McGeer EG, et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001;158:1039-51.
29. Burke AP, Tracy RP, Kolodgie F, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002;105:2019-23.
30. Bhakdi S, Torzewski M, Klouche M, et al. Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation. Arterioscler Thromb Vasc Biol 1999;19:2348-54.
31. Mold C, Gewurz H, Du Clos TW. Regulation of complement activation by C-reactive protein. Immunopharmocology 1999;42:23-30.
32. Zwaka TP, Homboch V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001;103:1194-7.
33. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-8.
34. Cermak J, Key NS, Bach RR, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513-20.